Semi-Annual Report — FY2026 H1
What COSMO BIO COMPANY,LIMITED reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-07View the original on EDINET
How much it says
28Almost nothing
What moved here
2named for the first time
Its own wording
12terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
For the six-month period ended June 2026, the filing states that net sales increased 9.5% year on year to ¥5,914 million and interim net income attributable to owners of the parent increased 10.5% to ¥277 million. It also states that there were no material changes in the business or business-related risks during the interim consolidated accounting period, and no changes among major affiliated companies.
Komori's summary of this document, not the document's own words.28Almost nothing
How much this filing saysA weighted roll-up of 9 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 31 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
52
Typical
0
Almost nothing
48
Typical
75
Very detailed
0
Almost nothing
0
Almost nothing
7
Almost nothing
79
Very detailed
10
Almost nothing
R&D spend70百万円Money spent making new things.
Cash left over9億円Cash from the business, less what went into equipment.
Spent on equipment1億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.